Biotech stocks down at noon
Wednesday, 11 March, 2009
At 12:30pm the pharmaceuticals index was down 1.3%, bucking the positive overall trend on the ASX which was up almost 2% after big rises on Wall Street overnight.
Index heavyweight CSL (ASX:CSL) accounted for the bulk of the slippage with a drop of 77c to $34.68.
Prana Biotechnology (ASX:PBT) moved up 1.5c, or over 9%, to 17.5c.
Novogen (ASX:NRT) also showed a 6% increase up 2.5c to 45c from yesterday’s lows.
Sigma Pharmaceuticals (ASX:SIP) was down 1% to 95c in light volume.
Russia insists there is "no plague case" following lab worker death
Russian health authorities say there is no evidence that pneumonic plague played a part in the...
Scientists 'reprogram' tumour-supporting immune cells
The approach, by an Australian team, uses lipid nanoparticles to target a type of immune cell...
Existing medicines could help treat deadly childhood dementia
Australian researchers have identified several existing TGA‑approved medicines that could help...
